BioGend Therapeutics Co Ltd

ROCO:6733 (Taiwan)   Ordinary Shares
NT$ 34.30 (+1.33%) Dec 26
At Loss
P/B:
4.86
Market Cap:
NT$ 4.26B ($ 130.00M)
Enterprise V:
NT$ 3.64B ($ 110.97M)
Volume:
78.00K
Avg Vol (2M):
159.24K
Trade In:
Volume:
78.00K
At Loss
Avg Vol (2M):
159.24K

BioGend Therapeutics Co Ltd Stock Institutional Ownership and Insider Ownership - ROCO:6733

124.26
(Mil)
Shares Outstanding
0.08%
0.10 (Mil)
Institutional Ownership

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of BioGend Therapeutics Co Ltd. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of BioGend Therapeutics Co Ltd. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders